AMRZ vs GFI

The company exhibits a Piotroski F-Score of 4/9, indicating stable but not robust financial health, while the absence of an Altman Z-Score limits distress risk assessment. Valuation metrics suggest the stock trades at a premium to both the Graham Number ($35.19) and intrinsic value ($16.52), supported by a high P/E of 22.98 versus sector peers. Despite solid operating margins and manageable leverage, earnings growth is negative year-over-year and quarterly earnings surprises have been inconsistent. Analysts recommend a 'buy' with a target price of $60.08, implying upside, but weak recent price performance and lack of dividend or insider activity temper near-term conviction.

GFI exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a very low Debt/Equity ratio of 0.37. While the current price of $44.99 is significantly above the defensive Graham Number ($20.44), it remains well below the growth-based intrinsic value of $116.23. The company is delivering massive profitability with an ROE of 51.93% and explosive YoY earnings growth of 196.10%. Despite a bearish technical trend and lukewarm insider sentiment, the fundamental value proposition and analyst targets suggest significant upside.